Sep 16 2009
"The $100 billion medical-device industry is scrambling to reverse billions of dollars in fees proposed by the Senate Finance Committee, but it faces trouble because its reluctance to offer concessions alienated some lawmakers," the
Wall Street Journal reports. The new fees, which are part of the debate surrounding sweeping health reform legislation, would add up to around $40 billion over ten years and would be based on a device-maker's market share. Both congressional aides and device company officials described an effort by the industry to avoid giving up any savings during a White House meeting with other industry groups this spring. Drug makers offered $80 billion in savings while hospitals promised $155 billion. Top lawmakers viewed the device industry's reluctance as an overreach. An aide said, "You either come to the table early, or you end up part of the dinner" (Mundy, 9/15).
This is part of Kaiser Health News' Daily Reports - a summary of health policy coverage from more than 300 news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Reports here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.
 This article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|